Brentuximab vedotin (Adcetris®) with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCL). Update July 2020

Grössmann, N. (2020): Brentuximab vedotin (Adcetris®) with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCL). Update July 2020. Oncology Fact Sheet Nr. 5.

[thumbnail of Oncology Fact Sheet Nr.5_Update.pdf]

Preview

PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
77kB

Item Type:	Oncology Fact Sheet
Subjects:	WB Practice of medicine > WB 300-962 Therapeutics WH Hemic and lymphatic systems QZ Pathology > QZ 200-380 Neoplasms.Cysts QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:	English
Series Name:	Oncology Fact Sheet Nr. 5
Deposited on:	15 Apr 2020 14:20
Last Modified:	31 Jul 2020 09:46

Repository Staff Only: item control page